----

----

| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-----|-----------------------------------------------------------------------------------------|

| [  ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|----------------|------------------------------------------------------------------------------------------|

| Delaware                                 | 59-2758596          |
|------------------------------------------|---------------------|
| (State or other jurisdiction of          | (I.R.S. Employer    |
|  incorporation or organization)     | Identification No.) |
|                                     |                |
| 354 Eisenhower Parkway                   |                |
| Livingston, New Jersey                   | 07039               |
| (Address of principal executive offices) | (Zip Code)          |

----

----

|                                                                                                         |    | September 30,                                                                                                                                                                               |   |    | December 31,                                                                                                                                                                                |
|--------------------------------------------------------------------------------------------------------------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                         |    | 2010                                                                                                                                                                                        |   |    | 2009                                                                                                                                                                                        |
|                                                                                                         |    | (Unaudited)                                                                                                                                                                                 |   |    |                                                                                                                                                                                        |
| ASSETS                                                                                                       |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| Current Assets:                                                                                              |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Cash and cash equivalents of which $8,240,760 in 2010 and                            |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        $12,225,732 in 2009 is interest bearing                            |  $ |                22,434,558                                                                                        |   |  $ |                14,757,615                                                                                        |
|     Accounts receivable, net of allowances for doubtful accounts                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        of $100,000 in 2010 and 2009, respectively (including              |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        amounts from related parties: 2010 - $576,749; 2009 - $0)          |    |                  2,447,988                                                                             |   |    |                  4,262,851                                                                             |
|     Inventories                                                                          |    |                  2,766,766                                                                             |   |    |                  2,532,722                                                                             |
|     Prepaid expenses and other current assets                                            |    |                     218,169                                                             |   |    |                  1,097,525                                                                             |
|        Total current assets                                               |    |                27,867,481                                                                                        |   |    |                22,650,713                                                                                        |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Property and equipment, net                                                          |    |                     564,925                                                             |   |    |                     691,479                                                             |
|     Intangible assets, net                                                               |    |                                - |   |    |                18,770,332                                                                                        |
|     Other assets                                                                         |    |                     483,883                                                             |   |    |                  1,644,695                                                                             |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| TOTAL ASSETS                                                                                                 |  $ |                28,916,289                                                                                        |   |  $ |                43,757,219                                                                                        |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| LIABILITIES AND SHAREHOLDERS' DEFICIT                                                                        |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| Current Liabilities:                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Current portion of financing agreements                                              |  $ |                              -             |   |  $ |                     144,897                                                             |
|     Accounts payable                                                                     |    |                  1,944,315                                                                             |   |    |                  3,662,091                                                                             |
|     Accrued expenses                                                                     |    |                  6,963,451                                                                             |   |    |                  4,588,088                                                                             |
|     Redeemable warrants                                                                  |    |                  5,643,021                                                                             |   |    |                              -             |
|        Total current liabilities                                          |    |                14,550,787                                                                                        |   |    |                  8,395,076                                                                             |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Notes payable                                                                        |    |                                - |   |    |                32,965,863                                                                                        |
|     Long-term portion of financing agreements                                            |    |                                - |   |    |                15,234,406                                                                                        |
|     Deferred revenue, (including amounts from related parites:                           |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        2010 - $25,554,840; 2009 - $0)                                     |    |                25,835,106                                                                                        |   |    |                     328,367                                                             |
|                                                                                                         |    |                40,385,893                                                                                        |   |    |                56,923,712                                                                                        |
| TOTAL LIABILITIES                                                                                            |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| COMMITMENTS AND CONTINGENCIES                                                                                |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Contingently Redeemable Series C Preferred Stock,                                    |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        600 shares issued and outstanding in 2010 and 2009,                |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        respectively (liquidation preference of $600,000)                  |    |                     600,000                                                             |   |    |                     600,000                                                             |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
| SHAREHOLDERS' DEFICIT:                                                                                       |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Preferred stock, $.01 par value;1,000,000 shares authorized                          |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|     Series B Convertible Preferred Stock, 130 shares issued and                          |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        outstanding (liquidation preference of $13,000)                    |    |                                1 |   |    |                                1 |
|     Series E Convertible Preferred Stock, 59,000 shares issued and                       |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        outstanding (liquidation preference of $5,900,000)                 |    |                            590                       |   |    |                            590                       |
|     Common Stock $.01 par value; 150,000,000 shares and 100,000,000                      |    |                                                                                                                                                                                        |   |    |
|        authorized in 2010 and 2009, respectively; 84,434,611 and          |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        65,761,986  shares issued in 2010 and 2009, respectively |    |                     844,345                                                             |   |    |                     657,619                                                             |
|     Capital in excess of par value                                                       |    |              264,496,821                                                                                                   |   |    |              242,637,646                                                                                                   |
|     Less cost of 3,521,499 and 131,935 treasury shares in                                |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |
|        2010 and 2009, respectively                                        |    |                (3,403,090)                                                                                       |   |    |                   (280,813)                                                                       |
|     Accumulated deficit                                                                  |    |            (274,194,519)                                                                                                             |   |    |            (256,979,263)                                                                                                             |
|     Accumulated other comprehensive income                                               |    |                     186,248                                                             |   |    |                     197,727                                                             |
|     Shareholders' deficit                                                                |    |              (12,069,604)                                                                                                  |   |    |              (13,766,493)                                                                                                  |
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                                                                  |  $ |                28,916,289                                                                                        |   |  $ |                43,757,219                                                                                        |
|                                                                                                         |    |                                                                                                                                                                                        |   |    |                                                                                                                                                                                        |

----

|                                                                                      |   | Nine Months Ended September 30,                                                                               |    |                                                                                                          | Three Months Ended September 30, |
|-------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------|---------|---------------------------------------------------------------------------------------------------------------|----------------------------------|
|                                                                                      |   | 2010                                                                                                          |    | 2009                                                                                                          |                             |   | 2010 |   | 2009 |
| REVENUES                                                                                  |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Net product revenues (including amounts from related parties:     |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        2010 - $581,104; 2009 - $0)                     | $      |     21,702,045                                                                            |  $ |     23,318,938                                                                            |                             | $ |       5,117,378 |  $ |       7,807,945 |
|     Royalties (including amounts from related parties:                |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        2010 - $450,000; 2009 - $0)                     |   |         544,349                                                       |    |         256,683                                                       |                             |   |         540,380 |   |           75,713 |
|     Other revenues (including amounts from related parties:           |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        2010 - $8,487,192; 2009 - $0)                   |   |       8,537,003                                                                 |    |           72,227                                            |                             |   |       8,503,655 |   |           19,299 |
|        Total net revenues                              |   |     30,783,397                                                                            |    |     23,647,848                                                                            |                             |   |     14,161,413 |   |       7,902,957 |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| COST OF PRODUCT REVENUES                                                                  |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Cost of product revenues (including amounts from related parties: |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        2010 - $528,473; 2009 - $0)                     |   |       6,232,062                                                                 |    |       6,680,929                                                                 |                             |   |       2,969,827 |   |       2,561,560 |
|     Gross profit                                                      |   |     24,551,335                                                                            |    |     16,966,919                                                                            |                             |   |     11,191,586 |   |       5,341,397 |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| OPERATING EXPENSES:                                                                       |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Selling and distribution                                          |   |       9,882,039                                                                 |    |       8,999,177                                                                 |                             |   |       3,925,408 |   |       3,096,810 |
|     General and administrative                                        |   |     12,451,067                                                                            |    |       7,708,514                                                                 |                             |   |       4,339,349 |   |       2,147,515 |
|     Research and development                                          |   |       6,609,318                                                                 |    |       6,206,028                                                                 |                             |   |       2,034,183 |   |       2,258,656 |
|     Amortization of licensing right                                   |   |       2,522,364                                                                 |    |       3,783,546                                                                 |                             |   |                   - |   |       1,261,182 |
|        Total operating expenses                        |   |     31,464,788                                                                            |    |     26,697,265                                                                            |                             |   |     10,298,940 |   |       8,764,163 |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        (Loss) income from operations                   |   |     (6,913,453)                                                                           |    |     (9,730,346)                                                                           |                             |   |         892,646 |   |     (3,422,766) |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| OTHER INCOME (EXPENSE):                                                                   |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Interest income                                                   |   |           24,625                                            |    |           33,801                                            |                             |   |           22,416 |   |             5,057 |
|     Interest expense                                                  |   |     (4,832,641)                                                                           |    |     (6,488,859)                                                                           |                             |   |          (12,549) |   |     (2,283,524) |
|     Change in fair value of derivative                                |   |                   - |    |                   - |                             |   |       4,829,036 |   |                   - |
|     Loss on debt extinguishment                                       |   |     (5,156,775)                                                                           |    |                   - |                             |   |     (5,156,775) |   |                   - |
|     Change in fair value of redeemable warrants                       |   |        (133,128)                                                           |    |                   - |                             |   |        (133,128) |   |                   - |
|     Other, net                                                        |   |        (201,684)                                                           |    |        (225,156)                                                           |                             |   |        (184,024) |   |        (152,029) |
|        Total other expenses                            |   |    (10,299,603)                                                                                |    |     (6,680,214)                                                                           |                             |   |        (635,024) |   |     (2,430,496) |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|        (Loss) Income before taxes                      |   |    (17,213,056)                                                                                |    |    (16,410,560)                                                                                |                             |   |         257,622 |   |     (5,853,262) |
|     State income taxes                                                |   |           (2,200)                                           |    |          (16,930)                                                |                             |   |                   - |   |                   - |
| NET (LOSS) INCOME                                                                         | $      |    (17,215,256)                                                                                |  $ |    (16,427,490)                                                                                |                             | $ |         257,622 | $ |     (5,853,262) |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| NET (LOSS) INCOME PER COMMON SHARE:                                                       |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Basic                                                             | $      |             (0.24)                                | $       |             (0.30)                                |                             | $ |              0.00 | $ |             (0.11) |
|     Diluted                                                           | $      |             (0.24)                                | $       |             (0.30)                                |                             | $ |              0.00 | $ |             (0.11) |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| WEIGHTED AVERAGE NUMBER OF                                                                |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
| COMMON SHARES OUTSTANDING:                                                                |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|     Basic                                                             |   | 70,987,668                                                                                                    |    | 54,397,545                                                                                                    |                             |   | 82,010,063 |   | 54,455,731 |
|     Diluted                                                           |   | 70,987,668                                                                                                    |    | 54,397,545                                                                                                    |                             |   | 82,010,063 |   | 54,455,731 |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |
|                                                                                      |   |                                                                                                          |    |                                                                                                          |                             |   |   |   |   |

----

|                               |                         |     | Nine Months Ended September 30, |   | Three Months Ended September 30,       |
|------------------------------------|------------------------------|----------|---------------------------------|--------|----------------------------------------|
|                               |                         |     | 2010                            |   | 2009                                   |   | 2010 |   | 2009 |
|                               |                         |     |                            |   |                                   |   |   |   |   |
| NET (LOSS) INCOME                  |  $ (17,215,256)         |     |  $ (16,427,490)            |   |  $    257,622 |   |  $(5,853,262) |
|                               |                         |     |                            |   |                                   |   |   |   |   |
| Other comprehensive (loss) income: |                         |     |                            |   |                                   |   |   |
|                               | Foreign currency translation | (11,479) |                            | 26,268 |                                   | 12,032 |   | 7,427 |
|                               |                         |     |                            |   |                                   |   |   |   |   |
| COMPREHENSIVE (LOSS) INCOME        |  $ (17,226,735)         |     |  $ (16,401,222)            |   |  $    269,654 |   |  $(5,845,835) |
|                               |                         |     |                            |   |                                   |   |   |   |   |
|                               |                         |     |                            |   |                                   |   |   |   |   |

----

|                                  |   | Series B ConvertiblePreferred Stock                             | Series E ConvertiblePreferred Stock | Common Stock                                       |            |                                 |     |                                     |                               |                                                                     |                                              |
|---------------------------------------|--------|-----------------------------------------------------------------|-------------------------------------|----------------------------------------------------|-----------------|--------------------------------------|----------|------------------------------------------|------------------------------------|--------------------------------------------------------------------------|---------------------------------------------------|
|                                  |   | Number ofShares                                                 | Amount                              |                                               | Number ofShares | Amount                               |     | Number ofShares                          | Amount                             |                                                                     |   Capital inExcess ofPar Value               |   |   TreasuryStock |   |   AccumulatedDeficit |   |   Accumulated OtherComprehensiveIncome (Loss) |   |   Total |
| Balance, December 31, 2009            |   |           130 |                                |  $       1 |            |      59,000 |     |  $     590 |                               |     65,761,986                                       |                                              |  $    657,619 |   |  $   242,637,646 |   |  $      (280,813) |   |  $   (256,979,263) |   |  $              197,727 |   |  $     (13,766,493) |
| Issuance of common stock and warrants | -      |                                                            |   -                            |                                               |   -        |                                 |   - |                                     |     18,607,407 |                                                                     |        186,074 |   |         19,196,706 |   |   - |   |   - |   |   - |   |           19,382,780 |
| Share based compensation expense      |   | -                                                               |                                |   -                                           |            |   -                             |     |   -                                 |                               |            65,218 |                                              |               652 |   |           2,684,969 |   |   - |   |   - |   |   - |   |             2,685,621 |
| Repurchase of company stock           |   |   -                                                        |                                |   -                                           |            |   -                             |     |   -                                 |                               |   -                                                                 |                                              |   - |   |   - |   |       (3,059,996) |   |   - |   |   - |   |           (3,059,996) |
| Purchase of treasury stock            |   |   -                                                        |                                |   -                                           |            |   -                             |     |   -                                 |                               |   -                                                                 |                                              |   - |   |   - |   |            (62,281) |   |   - |   |   - |   |                (62,281) |
| Dividends on preferred stock          |   |   -                                                        |                                |   -                                           |            |   -                             |     |   -                                 |                               |   -                                                                 |                                              |   - |   |               (22,500) |   |   - |   |   - |   |   - |   |                (22,500) |
| Translation adjustment                |   |   -                                                        |                                |   -                                           |            |   -                             |     |   -                                 |                               |   -                                                                 |                                              |   - |   |   - |   |   - |   |   - |   |                  (11,479) |   |                (11,479) |
| Net loss                              |   |   -                                                        |                                |   -                                           |            |   -                             |     |   -                                 |                               |   -                                                                 |                                              |   - |   |   - |   |   - |   |         (17,215,256) |   |   - |   |         (17,215,256) |
| Balance, September 30, 2010           |   |           130 |                                |  $       1 |            |      59,000 |     |  $     590 |                               |     84,434,611                                       |                                              |  $    844,345 |   |  $   264,496,821 |   |  $   (3,403,090) |   |  $   (274,194,519) |   |  $              186,248 |   |  $     (12,069,604) |
|                                  |   |                                                            |                                |                                               |            |                                 |     |                                     |                               |                                                                     |                                              |   |   |   |   |   |   |   |   |   |   |   |
|                                  |   |                                                            |                                |                                               |            |                                 |     |                                     |                               |                                                                     |                                              |   |   |   |   |   |   |   |   |   |   |   |

----

|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  | Nine Months Ended September 30,                                                                                           |
|---------------------------------------|--------------------------------------------------|------------------------------------------------------------|----------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  | 2010                                                                                                                      |   | 2009 |
| CASH FLOWS FROM OPERATING ACTIVITIES: |                                             |                                                       |                                                                             |
|                                  | Net loss                                         |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |  $   (17,215,256)                                                                                     |                                                                                                  |  $   (16,427,490)                                                                                     |
|                                  | Adjustments to reconcile net loss to net         |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |
|                                  |                                             | cash used in operating activities-                         |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |
|                                  |                                             |                                                       | Depreciation and amortization                                                    |                                                                                                                      |                                                                                                                      |          3,107,178                                                           |                                                                                                  |          4,211,858                                                           |
|                                  |                                             |                                                       | Amortization on beneficial conversion features                                   |             918,710                                           |                                                                                                                      |          1,222,692                                                           |
|                                  |                                             |                                                       | Amortization on warrant valuation                                                |                                                                                                                      |             673,852                                           |                                                                                                                      |             909,898                       |
|                                  |                                             |                                                       | Change in value of warrants                                                      |                                                                                                                      |                                                                                                                      |             133,128                                           |                                                                                                  |                     - |
|                                  |                                             |                                                       | Recognition of deferred income                                                   |                                                                                                                      |                                                                                                                      |         (8,537,003)                                                               |                                                                                                  |             (38,135)                                          |
|                                  |                                             |                                                       | Provision for sales returns                                                      |                                                                                                                      |                                                                                                                      |          1,633,424                                                           |                                                                                                  |             848,662                                           |
|                                  |                                             |                                                       | Writeoff of accounts receivable                                                  |                                                                                                                      |                                                                                                                      |               67,744                                |                                                                                                  |                     - |
|                                  |                                             |                                                       | Writedown of inventories                                                         |                                                                                                                      |                                                                                                                      |               42,595                                |                                                                                                  |                1,496                           |
|                                  |                                             |                                                       | Loss on extingquishment of debt                                                  |                                                                                                                      |                                                                                                                      |          5,156,775                                                           |                                                                                                  |                     - |
|                                  |                                             |                                                       | Stock based compensation                                                         |                                                                                                                      |                                                                                                                      |          2,685,621                                                           |                                                                                                  |          1,428,217                                                           |
|                                  |                                             |                                                       | Non-cash interest expense on financing agreements                                |          1,137,222                                                           |                                                                                                                      |          1,519,374                                                           |
|                                  | Changes in assets and liabilities-               |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |
|                                  |                                             | (Increase) decrease in:                                    |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |
|                                  |                                             |                                                       | Accounts receivable                                                              |                                                                                                                      |                                                                                                                      |                                                                                                                      |          1,747,119                                       |                                                                                                                      |             333,426 |
|                                  |                                             |                                                       | Inventories                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                                      |           (276,639)                                 |                                                                                                                      |               63,432 |
|                                  |                                             |                                                       | Prepaid expenses and other current assets                                        |                                                                                                                      |             879,356                                           |                                                                                                                      |             716,050                       |
|                                  |                                             |                                                       | Other assets                                                                     |                                                                                                                      |                                                                                                                      |                                                                                                                      |                 (737) |                                                                                                                      |                9,438 |
|                                  |  Increase (decrease) in:                    |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |
|                                  |                                             |                                                       | Accounts payable                                                                 |                                                                                                                      |                                                                                                                      |                                                                                                                      |         (1,717,776)                                           |                                                                                                                      |             397,226 |
|                                  |                                             |                                                       | Other accrued expenses                                                           |                                                                                                                      |                                                                                                                      |             704,747                                           |                                                                                                  |           (987,109)                                                     |
|                                  | Net cash used in operating activities            |                                                       |         (8,859,940)                      |                                                                                                                      |         (5,790,965)                                                               |
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |                                                                                                                      |   |   |
| CASH FLOWS FROM INVESTING ACTIVITIES: |                                             |                                                       |                                                                             |
|                                  | Purchase of property and equipment               |                                                       |             (34,864) |                                                                                                                      |             (48,039)                                          |
|                                  | Proceeds from sale of assets                     |                                                       |                                                                             |         35,240,000                                                                |                                                                                                                      |                     - |
|                                  |                                             |                                                       | Net cash provided by (used in) investing activities                              |         35,205,136                                                                |                                                                                                                      |             (48,039)                                          |
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |                                                                                                                      |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES: |                                             |                                                       |                                                                             |
|                                  | Net proceeds from the sale of common stock       |                                                       |         11,643,897                       |                                                                                                                      |             750,000                                           |
|                                  | Proceeds from financing agreements - Watson Note |         15,000,000 |                                                                             |                     - |
|                                  | Payment of note payable                          |                                                       |                                                                             |       (25,999,999)                                                                          |                                                                                                                      |                     - |
|                                  | Payments pursuant to financing agreements        |                                                       |       (16,155,903)                                 |                                                                                                                      |                     - |
|                                  | Repurchase of company stock                      |                                                       |                                                                             |         (3,059,996)                                                               |                                                                                                                      |                     - |
|                                  | Payments for purchase of treasury stock          |                                                       |             (62,281) |                                                                                                                      |             (91,584)                                          |
|                                  | Dividends paid                                   |                                                       |                                                                             |                                                                                                                      |             (22,500)                                          |                                                                                                                      |             (24,688)                      |
|                                  |                                             |                                                       | Net cash provided by (used in) financing activities                              |       (18,656,782)                                                                          |                                                                                                                      |             633,728                                           |
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |                                                                                                                      |   |   |
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |                                                                                                                      |   |   |
|                                  |                                             |                                                       |                                                                             |                                                                                                                      |                                                                                                                      |                                                                                                                      |                                                                                                  |                                                                                                                      |   |   |

----

|                                                                             |          |                                                                                                    |   Nine Months Ended September 30, |
|----------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------|----------------------------------------|
|                                                                             |          |                                                                                                    | 2010                                   |   | 2009 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH                                          |          |            (11,471)                              |                                   |   |             39,471 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| NET INCREASE (DECREASE) IN CASH                                                  |          |         7,676,943                                               |                                   |   |        (5,165,805) |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| CASH, BEGINNING OF PERIOD                                                        |          | 14,757,615                                                                                              |                                   |   | 12,497,382 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| CASH END OF PERIOD                                                               | $             |     22,434,558                                                                      |                                   |   $ |       7,331,577 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| NON-CASH FINANCING ACTIVITIES                                                    |          |                                                                                                    |                                   |   |   |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Conversion of Series C and Series E preferred shares     |  $       |               -                   |                                   |   $ |          175,000 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Issuance of Warrants for Option to Extend Pharmabio Debt |  $       |                  - |                                   |   $ |         719,904 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Forgiveness of Watson Note                               |   $ |    15,000,000                                                                            |                                   |   $ |                 - |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Net Issuance of Common Stock for Debt Retirement         |   $ |      7,738,883                                                                 |                                   |   $ |                  - |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Issuance of Warrants for Debt Retirement                 |   $ |      5,509,893                                                                 |                                   |   $ |                 - |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
| SUPPLEMENTAL INFORMATION                                                         |          |                                                                                                    |                                   |   |   |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Interest paid                                            |          | $                                                                                                       |     1,600,000      |   |   $ |       2,400,003 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|     Taxes paid                                               |          |                                                                                                    | $                                 |          58,256 |   |   $ |            31,634 |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |
|                                                                             |          |                                                                                                    |                                   |   |   |   |   |

----

----

----

|                                                                         | September 30,                                                                                                |   | December 31,                                                                                                                                            |
|------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                         | 2010                                                                                                         |   | 2009                                                                                                                                                    |
| Cash Proceeds from Watson Transaction and Debt Forgiveness:                  |  $        62,000,000                                            |   |  $                      -            |
|     Interest on Watson Note forgiven                     |                  50,000 |   |                                                                                                                                                    |
|     Common Stock                                         |          (11,760,000)                                           |   |                          - |
|        Gross Proceeds less Value of Stock |            50,290,000                                 |   |                                                                                                                                                    |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |
|     Net Book Value of Intangible Assets Sold to Watson   |          (16,247,968)                                           |   |                          - |
| Deferred Revenue related to Watson                                           |            34,042,032                                 |   |                                                                                                                                                    |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |
| 3rd Quarter Amortization of Deferred Revenue Related to Watson          |            (8,487,192)                                |   |                          - |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |
| Net Deferred Revenue - Watson                                                |            25,554,840                                 |   |                          - |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |
| Deferred Revenue - Other                                                     |                280,266            |   |                328,367                                                       |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |
| Deferred Revenue                                                             |  $        25,835,106                                            |   |  $            328,367                                                                  |
|                                                                         |                                                                                                         |   |                                                                                                                                                    |

----

|                                                    | Nine Months Ended September 30,                                      |
|---------------------------------------------------------|----------------------------------------------------------------------|
|                                                    | 2010                                                                 |   | 2009 |
|                                                    |                                                                 |   |   |
| Balance at beginning of year                            |  $     1,883,623                       |   |  $   1,864,316 |
|                                                    |                                                                 |   |   |
| Provision:                                              |                                                                 |   |   |
|     Related to current period sales | 745,405                                                              |   | 485,778 |
|     Related to prior period sales   |           888,019  |   |         362,884 |
|                                                    |        1,633,424                  |   | 848,662 |
|                                                    |                                                                 |   |   |
| Returns:                                                |                                                                 |   |   |
|     Related to current period sales |           (61,013) |   |          (17,896) |
|     Related to prior period sales   |         (745,945)            |   |        (933,321) |
|                                                    |         (806,958)            |   |        (951,217) |
|                                                    |                                                                 |   |   |
| Balance at end of quarter                               |  $     2,710,089                       |   |  $   1,761,761 |
|                                                    |                                                                 |   |   |

|           |   | September 30,                |   | December 31,                       |
|----------------|--------|------------------------------|--------|------------------------------------|
|           |   | 2010                         |   | 2009                               |
| Finished goods |   |  $  1,605,605 |   |  $   1,343,742 |
| Raw materials  |   | 1,161,161                    |   | 1,188,980                          |
|           |   |                         |   |                               |
|           |   |  $  2,766,766 |   |  $   2,532,722 |
|           |   |                         |   |                               |

----

----

----

|   Net Book Value of Long-Term Notes Payable                                       |                                                                                                                |    $          34,558,425                            |
|----------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|
|                                                                                   |                                                                                                                |                                                                                                            |
|                                                                                   |                                                                                                                |                                                                                                            |
| Consideration:                                                                         | Number of shares                                                                                                    |                                                                                                            |
|     Stock issued to Noteholders                                         |          7,407,407                                                     |               (7,777,777)                 |
|     Cash                                                           |                                                                                                                |             (25,999,999)                       |
|     Warrants to purchase shares of Common Stock                         |          7,750,000                                                     |               (5,509,893)                 |
|                                                                                   |                                                                                                                |                                                                                                            |
|     Loss on Extinguishment of Notes                                     |                                                                                                                |               (4,729,244)                 |
|                                                                                   |                                                                                                                |                                                                                                            |
|     Gain (Loss) on Debt Extinguishment of PharmaBio Debt Extinguishment |                   310,622 |
|     Write-off of Deferred Charges                                  |                                                                                                                |                  (738,153) |
|     Net Loss on Debt Extinguishment                                     |                                                                                                                |  $           (5,156,775)                            |

----

|                          |                |                                                            | Net                                             |                                                                                                                      | Identifiable                                    |
|-------------------------------|---------------------|-----------------------------------------------------------------|-------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------|
|                          |                |                                                            | Revenues                                        |                                                                                                                      | Assets                                          |
|                          |                |                                                            |                                            |                                                                                                                      |                                            |
| As of and for the nine months |                |                                                            |                                            |
| ended September 30, 2010      |                |                                                            |                                            |
|                          | United States       |  $     21,422,766                 |                                            |  $     24,697,531                                                                           |
|                          |                |                                                            |                                            |                                                                                                                      |                                            |
|                          | Switzerland         |          7,694,077 |                                            |          4,218,758                                                           |
|                          | Other countries     |          1,666,554 |                                            |                     - |
|                          | Total International |          9,360,631 |                                            |          4,218,758                                                           |
|                          | Total               |                                                            |  $     30,783,397 |                                                                                                                      |  $     28,916,289 |
|                          |                |                                                            |                                            |                                                                                                                      |                                            |
| As of and for the nine months |                |                                                            |                                            |
| ended September 30, 2009      |                |                                                            |                                            |
|                          | United States       |  $     14,442,536                 |                                            |  $     31,775,481                                                                           |
|                          |                |                                                            |                                            |                                                                                                                      |                                            |
|                          | Switzerland         |          6,513,979 |                                            |          4,113,445                                                           |
|                          | Other countries     |          2,691,333 |                                            |                     - |
|                          | Total International |          9,205,312 |                                            |          4,113,445                                                           |
|                          | Total               |                                                            |  $     23,647,848 |                                                                                                                      |  $     35,888,926 |
|                          |                |                                                            |                                            |                                                                                                                      |                                            |

----

|                                |                            |                 | Nine Months Ended September 30,                                           |                 | Three Months Ended September 30,                                          |
|-------------------------------------|---------------------------------|----------------------|---------------------------------------------------------------------------|----------------------|---------------------------------------------------------------------------|
|                                |                            |                 | 2010                                                                      |                 | 2009                                                                      |   | 2010 |   | 2009 |
| NET (LOSS) INCOME                   |  $ (17,215,256)            |                 |  $ (16,427,490)                                                      |                 |  $    257,622                                    |   |  $(5,853,262) |
|                                | Less: Preferred stock dividends | (22,500)             |                                                                      | (24,688)             |                                                                      | (7,500) |   | (7,500) |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |
| NET (LOSS) INCOME APPLICABLE TO     |                            |                 |                                                                      |                 |                                                                      |   |   |
|                                | COMMON STOCK                    |  $ (17,237,756) |                                                                      |  $ (16,452,178) |                                                                      |  $    250,122 |   |  $(5,860,762) |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |
| NET (LOSS) INCOME PER COMMON SHARE: |                            |                 |                                                                      |                 |                                                                      |   |   |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |
|                                | Basic                           |                 |  $          (0.24) |                 |  $          (0.30) |   |  $         0.00 |   |  $        (0.11) |
|                                | Diluted                         |                 |  $          (0.24) |                 |  $          (0.30) |   |  $         0.00 |   |  $        (0.11) |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |
| WEIGHTED AVERAGE NUMBER OF          |                            |                 |                                                                      |                 |                                                                      |   |   |
|                                | COMMON SHARES OUTSTANDING:      |                 |                                                                      |                 |                                                                      |   |   |   |
|                                | Basic                           |                 | 70,987,668                                                                |                 | 54,397,545                                                                |   | 82,010,063 |   | 54,455,731 |
|                                | Diluted                         |                 | 70,987,668                                                                |                 | 54,397,545                                                                |   | 82,010,063 |   | 54,455,731 |
|                                |                            |                 |                                                                      |                 |                                                                      |   |   |   |   |

----

|                       |   | Nine Months Ended September 30,                                                 |
|----------------------------|--------|---------------------------------------------------------------------------------|
| Stock Based Compensation   |   | 2010                                                                            |   | 2009 |
|                       |   |                                                                            |   |   |
| Cost of revenues           |   |  $         133,543            |   |  $          58,253 |
|                       |   |                                                                            |   |   |
| Selling and distribution   |   |          1,118,221                 |   |            364,566 |
|                       |   |                                                                            |   |   |
| General and administrative |   |          1,200,860                 |   |            897,890 |
|                       |   |                                                                            |   |   |
| Research and development   |   |             232,997 |   |            107,508 |
|                       |   |                                                                            |   |   |
| Total                      |   |  $      2,685,621                            |   |  $      1,428,217 |
|                       |   |                                                                            |   |   |

----

|                                                        |   | Nine Months Ended September 30,             |    |                                                                                                          | Three Months Ended September 30, |
|-------------------------------------------------------------|--------|---------------------------------------------|---------|---------------------------------------------------------------------------------------------------------------|----------------------------------|
|                                                        |   | 2010                                        |    | 2009                                                                                                          |                             |   | 2010 |   | 2009 |
| REVENUES                                                    |   |                                        |    |                                                                                                          |                             |   |   |   |   |
|     Net product revenues                | $      |       581,104 |  $ |                   - |                             | $ |      581,104 |  $ |                   - |
|                                                        |   |                                        |    |                                                                                                          |                             |   |   |   |   |
|     Royalties                           |   |       450,000 |    |                   - |                             |   |      450,000 |   |                   - |
|                                                        |   |                                        |    |                                                                                                          |                             |   |   |   |   |
|     Other revenue (amortization of      |   |                                        |    |                                                                                                          |                             |   |   |   |   |
|        deferred revenue) |   |    8,487,192                 |    |                   - |                             |   |   8,487,192 |   |                   - |
|     Total net revenues                  |   |    9,518,296                 |    |                   - |                             |   |   9,518,296 | $ |                   - |
|                                                        |   |                                        |    |                                                                                                          |                             |   |   |   |   |
| COST OF PRODUCT REVENUES                                    |   |                                        |    |                                                                                                          |                             |   |   |   |   |
|     Cost of product revenues            |   |       528,473 |    |   -                                                                                                      |                             |   |      528,473 |   |   - |
|        Gross profit      | $      |    8,989,823                 | $       |                   - |                             | $ |   8,989,823 | $ |                   - |
|                                                        |   |                                        |    |                                                                                                          |                             |   |   |   |   |

----

| Product Revenues include                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      · CRINONE 8% (progesterone gel) marketed and sold by us in the U.S. through July  2, 2010, and sold to Watson for resale in the U.S. beginning after July 2, 2010;     · CRINONE 8% sold to Merck Serono for resale outside the U.S.;     · PROCHIEVE 8% (progesterone gel) sold by us in the U.S. through July 1, 2010 and sold to Watson for resale in the U.S. beginning after July 2, 2010;     · PROCHIEVE 4% sold to Ascend Therapeutics, Inc., for resale in the U.S., pursuant to an agreement that terminated on July 23, 2010 and sold to Watson on July 2, 2010 for resale in the U.S. beginning after July 23, 2010;     · STRIANT (testosterone buccal system) marketed and sold by us in the U.S.  |

----

----

----

----

----

|                 | Nine Months Ended September 30, |
|----------------------|---------------------------------|
|                 | 2010                            |   | 2009 |
| Cash flows:          |                            |   |   |
| Operating activities |  $ (8,859,940)             |   |  $(5,790,965) |
| Investing activities |    35,205,136    |   |        (48,039) |
| Financing activities |   (18,656,782)        |   |        (24,688) |
|                 |                            |   |   |

----

----

|            | (a) Total Number of Shares (or Units) Purchased | (b) Average Price Paid per Share (or Unit) | (c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs |
|-----------------|-------------------------------------------------|--------------------------------------------|-------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| August 2010 (1) | 3,333,330 shares of Common Stock                | $ 0.90                                |  ─                                                                                   |  ─                                                                                                               |

|   | (1) | On August 9, 2010, Columbia entered into a Securities Purchase Agreement with Perry Partners International Inc. and Perry Partners, L.P., pursuant to which the Company repurchased, at $0.90 per share, for an aggregate purchase price of approximately $3.0 million, 3,333,330 shares of its Common Stock. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                    | Nine Months Ended September 30, |
|-------------------------|---------------------------------|
|                    | 2010                            | 2009 |
| Risk free interest rate | 1.38%                           | 2.40% |
| Expected term           | 4.75                            | 4.75 years |
| Dividend yield          | -                               | - |
| Expected volatility     | 92.45%                          | 93.44% |

----

----

----

----

----

----

| ·   | Clinical trials may show our product candidates to be ineffective for the indications studied or to have harmful side effects; |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------|

| ·   | Product candidates may fail to receive regulatory approvals required to bring the products to market; |
|--------------------|-------------------------------------------------------------------------------------------------------|

| ·   | Manufacturing costs or other factors may make our product candidates uneconomical; and |
|--------------------|----------------------------------------------------------------------------------------|

| ·   | The proprietary rights of others and their competing products and technologies may prevent our product candidates from being effectively commercialized. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | The rate of patient enrollment which is a function of factors including the size of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the study, and the nature of the study protocol; |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Institutional Review Board, or IRB, approval of the study protocol and the informed consent forms; |
|--------------------|----------------------------------------------------------------------------------------------------|

| ·   | Prior regulatory agency review and approval; |
|--------------------|----------------------------------------------|

| ·   | Analysis of data obtained from clinical activities, which are susceptible to varying interpretations and which interpretations could delay, limit or prevent regulatory approval; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Changes in the policies of regulatory authorities for drug approval during the period of product development; and |
|--------------------|-------------------------------------------------------------------------------------------------------------------|

| ·   | The availability of skilled and experienced staff to conduct and monitor clinical studies and to prepare the appropriate regulatory applications. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Our ability to raise any additional funds that we need to complete our trials; |
|--------------------|--------------------------------------------------------------------------------|

| ·   | The number and outcome of clinical trials conducted by us and/or our collaborators; |
|--------------------|-------------------------------------------------------------------------------------|

| ·   | The number of products we may have in clinical development; |
|--------------------|-------------------------------------------------------------|

| ·   | In licensing or other partnership activities, including the timing and amount of related development funding, license fees or milestone payments; and |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Future levels of our revenue. |
|--------------------|-------------------------------|

----

| ·   | A product candidate may not be deemed to be safe or effective; |
|--------------------|----------------------------------------------------------------|

| ·   | The manufacturing processes or facilities we have selected may not meet the applicable requirements; and |
|--------------------|----------------------------------------------------------------------------------------------------------|

| ·   | Changes in their approval policies or adoption of new regulations may require additional clinical trials or other data. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------|

----

----

----

----

----

----

|     (a)  Unregistered Sales of Equity Securities |
|--------------------------------------------------------------------------------|

|     (b)   | Not applicable. |
|-----------------------------------------|-----------------|

|     (c)   | Stock Repurchase |
|-----------------------------------------|------------------|

|            | (a) Total Number of Shares (or Units) Purchased | (b) Average Price Paid per Share (or Unit) | (c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs |
|-----------------|-------------------------------------------------|--------------------------------------------|-------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| August 2010 (1) | 3,333,330 shares of Common Stock                | $ 0.90                                |  ─                                                                                   |  ─                                                                                                               |

| (1) | On August 9, 2010, Columbia entered into a Securities Purchase Agreement with Perry Partners International Inc. and Perry Partners, L.P., pursuant to which the Company repurchased, at $0.90 per share, for an aggregate purchase price of approximately $3 million, 3,333,330 shares of its Common Stock. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | None. |
|--------|-------|

| (a)   | Exhibits |
|-----------------|----------|

| 3.1  | Certificate of Amendment to Restated Certificate of Incorporation of Columbia Laboratories, Inc., filed with the Secretary of State of Delaware July 1, 2010. (1) |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.1  | Form of Warrant to Purchase Common Stock. (1)                                                                                                                          |
| 10.1 | Second Amended and Restated License and Supply Agreement between Columbia Laboratories (Bermuda) Ltd., and Ares Trading S.A., effective May 19, 2010. *           |
| 10.2 | Securities Purchase Agreement, dated as of August 9, 2010 (2)                                                                                                          |
| 10.3 | Investor’s Rights Agreement, dated July 1, 2010. (1)                                                                                                        |
| 10.4 | Watson Supply Agreement, dated July 2, 2010. (1)                                                                                                                  |
| 10.5 | Watson License Agreement, dated July 2, 2010. (1)                                                                                                                 |
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer of the Company.*                                                                                     |
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer of the Company.*                                                                                     |
| 32.1 | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**                                              |
| 32.2 | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**                                              |

|   | * | Filed herewith. |
|--------|---|-----------------|

|   | ** | Furnished herewith. |
|--------|----|---------------------|

|   | (1) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, dated July 1, 2010 |
|--------|-----|----------------------------------------------------------------------------------------------------|

|   | (2) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, dated August 9, 2010 |
|--------|-----|------------------------------------------------------------------------------------------------------|

----

|   | SIGNATURES |
|--------|------------|

----

----